Product NDC: | 0703-8411 |
Proprietary Name: | Enalaprilat |
Non Proprietary Name: | enalaprilat |
Active Ingredient(s): | 1.25 mg/mL & nbsp; enalaprilat |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-8411 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075578 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051006 |
Package NDC: | 0703-8411-04 |
Package Description: | 25 VIAL in 1 TRAY (0703-8411-04) > 2 mL in 1 VIAL (0703-8411-01) |
NDC Code | 0703-8411-04 |
Proprietary Name | Enalaprilat |
Package Description | 25 VIAL in 1 TRAY (0703-8411-04) > 2 mL in 1 VIAL (0703-8411-01) |
Product NDC | 0703-8411 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | enalaprilat |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20051006 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | ENALAPRILAT |
Strength Number | 1.25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |